Management Team

Robert Brooks, J.D.
Founder, Chairman, Chief Executive Officer

Robert brings 25 years of life science capital market and corporate counsel experience.He founded the Company, and has served as Chairman and Chief Executive. Prior to Aurora, Robert founded and served as Chief Executive Officer of Medvax Technologies, a clinical stage cancer immunotherapy company developing dendritic cell and peptide cancer vaccines. Robert has been corporate counsel to numerous life science companies. He has participated in over $500 million of private and public offerings of life science and growth companies in the capital markets. He received his B.S. in Biology (pre-medicine concentration) Cum Laude from the University of Massachusetts, and Juris Doctorate from the University of Miami Law School. He has held a Series 7 securities license.

Marc Lippman, M.D.
Founder Chief Scientific Advisor
Board Member

Marc is the Kathleen and Stanley Glaser Professor of Medicine and Deputy Director of the University of Miami Sylvester Comprehensive Cancer Center. Previously, from February 2001 to May 2007 he served as the John G. Searle Professor and Chairman of the Department of Internal Medicine at the University of Michigan School of Medicine. Previously, Dr. Lippman was the Director of the Lombardi Cancer Research Center from July 1988 to February 2001, Professor and Chairman of the Department of Oncology from July 1999 to February 2001 and Professor of Medicine at Georgetown University Medical School in Washington, D.C. from July 1988 to February 2001. He also served as Chief of the Division of Hematology-Oncology at Georgetown University Medical School from July 1995 to February 2001. He was Head of the Medical Breast Cancer Section of the Medicine Branch of the National Cancer Institute from July 1976 to July 1988. Dr. Lippman has authored over 500 peer- reviewed publications.

Richard Berman,MBA
Director
Richard Berman is a member of the Board of Directors. Mr. Berman’s business career spans over 35 years of venture capital, senior management and merger and acquisitions experience. In the past five years, Mr. Berman has served as a director and/or officer of over a dozen public and private companies. From 2006 to 2011, he was Chairman of National Investment Managers, a company with $12 billion in pension administration assets. From 1998 to 2012, Mr. Berman served as a Director of Easy Link Int’l. Mr. Berman is currently a director of four public companies: Advaxis, Inc., Neostem, Inc., Cryoport, Inc. and Lustros, Inc. Previously, Mr. Berman worked at Goldman Sachs; was Senior Vice President of Bankers Trust Company, where he started the M&A and Leveraged Buyout Departments; created the largest battery company in the world in the 1980s by merging Prestolite, General Battery and Exide to form Exide Technologies (XIDE); and advised on over $4 billion of M&A transactions (completed over 300 deals). He is a past Director of the Stern School of Business of NYU where he obtained his Bachelor of Science and Master of Business Administration. He also has U.S. and foreign law degrees from Boston College and The Hague Academy of International Law.